Improving the quality of cancer clinical trials workshop summary /
Сохранить в:
| Корпоративные авторы: | , , |
|---|---|
| Другие авторы: | , |
| Формат: | Электронный ресурс eКнига |
| Язык: | английский |
| Опубликовано: |
Washington, D.C. :
National Academies Press,
c2008.
|
| Предметы: | |
| Online-ссылка: | An electronic book accessible through the World Wide Web; click to view |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Оглавление:
- Introduction
- New clinical trial designs. Phase 0 trials
- Adaptive trial designs
- Targeting multiple pathways with multiple drugs
- Preclinical model systems
- Molecular imaging. Current and developing methods
- Challenges of molecular imaging
- Screening for predictive markers. The challenges of clinical validation
- Bioimaging predictive markers
- Clinical translation
- Panel discussion
- Costs of clinical trials. Regulatory costs
- Patient accrual
- Global outsourcing
- Time is money
- Public-private collaborations
- Regulatory issues. Regulatory barriers to innovation
- Patient advocacy perspective
- Regulation of in vitro diagnostics
- Regulatory issues in improving cancer clinical trials
- Reports from the case study discussion groups. Adaptive trial design
- Phase 0 trials
- Imaging
- Use of proteomics/genomics to assign therapy in lung cancer
- Use of genetics/genomics to assign therapy.